Heart Test Laboratories Inc (HSCS)

$3.24 -0.13 (-3.86%)
Market Cap 2.27M
Revenue (ttm) 20,000.00
Net Income (ttm) -6.61M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 11,938
Avg Vol 455,542
Day's Range N/A - N/A
Shares Out 656,000.00
Stochastic %K 24%
Beta 3.16
Analysts Strong Sell
Price Target $13.50

Company Profile

HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventi...

Industry: Medical Devices
Sector: Healthcare
Phone: 682 237 7781
Address:
550 Reserve Street, Suite 360, Southlake, United States
14745Barclay
14745Barclay Apr. 5 at 3:48 AM
$HSCS The COO died of cancer. Is the company finally able to do something substantial now? He was largely missing from operation due to illness.
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 3 at 1:17 AM
$HSCS
0 · Reply
StarlinePalaceTrades
StarlinePalaceTrades Apr. 2 at 5:55 PM
$HSCS that s-1 open or no?
0 · Reply
Moneyybaggs
Moneyybaggs Apr. 1 at 8:48 AM
$HSCS @DrTampa, somebody else, besides you and me, was FINALLY buying the stock yesterday!!! Let’s hope they’re back buying today. There is hardly any liquidity. SP was up 11% on just under 19K being traded. There’s hardly any shares in the float. Good luck building a sizable position without moving the SP $1-2. That PR last week regarding EPIC selection as a vendor in their web store is a GAME CHANGER!!! We are on the right train!!! UNCONTROLLABLY
1 · Reply
DrTampa
DrTampa Mar. 31 at 7:23 PM
$HSCS Nice inflow today with the share price up 11%
0 · Reply
DrTampa
DrTampa Mar. 30 at 4:43 PM
$HSCS that mid day spread tho 👀👀👀
0 · Reply
DrTampa
DrTampa Mar. 30 at 1:23 AM
$HSCS was so busy I missed this PR release last week, but it's now official news that Heart Sciences is listed on EPIC'S showroom! Now, we just need revenues!!! https://ir.heartsciences.com/release?i=163521
0 · Reply
PrnceMichael
PrnceMichael Mar. 27 at 2:42 PM
$OLOX $GMEX $GVH $UCAR $HSCS
0 · Reply
lovelylee
lovelylee Mar. 27 at 1:17 PM
$AIFU $GVH $HSCS $OSRH $UCAR $OSRH- best opportunity today! $10 price target, no dilution, low entry
0 · Reply
Verdelechugita
Verdelechugita Mar. 27 at 12:20 PM
$OLOX Based on news, fundamentals, and the exaggerated drop, it should already be above $1.60. Personal opinion. ✔️Likely big bounce ✔️Small market cap ✔️No short positions ✔️Small free float March 9th: $1.20 to $2.19 🚀 Today it's at $1.05... volume is coming in, interest is returning 👀 Today's pre-market Gainers 🚀 $GMEX $GVH $UCAR $HSCS
0 · Reply
Latest News on HSCS
HeartSciences' MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category

Mar 25, 2026, 8:30 AM EDT - 11 days ago

HeartSciences' MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category

HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings

Mar 24, 2026, 11:18 AM EDT - 11 days ago

HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings

HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

Mar 16, 2026, 4:15 PM EDT - 19 days ago

HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

University of West England Adopts HeartSciences' MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center

Feb 5, 2026, 8:30 AM EST - 2 months ago

University of West England Adopts HeartSciences' MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center

Cibolo Health Designates HeartSciences' MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals

Jan 29, 2026, 8:30 AM EST - 2 months ago

Cibolo Health Designates HeartSciences' MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals

HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

Dec 15, 2025, 4:15 PM EST - 3 months ago

HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device

Dec 15, 2025, 8:30 AM EST - 3 months ago

HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device

HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1

Dec 11, 2025, 8:30 AM EST - 4 months ago

HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1

HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results

Sep 11, 2025, 4:15 PM EDT - 7 months ago

HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results

HeartSciences Announces Conference Participation and Investor Webinar

Aug 15, 2025, 9:00 AM EDT - 8 months ago

HeartSciences Announces Conference Participation and Investor Webinar

HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results

Jul 24, 2025, 4:15 PM EDT - 9 months ago

HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results

HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

Jun 4, 2025, 9:00 AM EDT - 10 months ago

HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value

Jun 3, 2025, 9:00 AM EDT - 10 months ago

Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

May 29, 2025, 9:00 AM EDT - 11 months ago

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025

May 20, 2025, 9:00 AM EDT - 11 months ago

HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025

HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson

May 8, 2025, 9:00 AM EDT - 11 months ago

HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson

HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

May 7, 2025, 9:00 AM EDT - 11 months ago

HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

May 1, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

Mar 13, 2025, 4:15 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

Mar 10, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

Dec 16, 2024, 4:15 PM EST - 1 year ago

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

Nov 13, 2024, 9:00 AM EST - 1 year ago

HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 14, 2024, 4:15 PM EDT - 1 year ago

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

Sep 12, 2024, 4:15 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

Sep 12, 2024, 9:00 AM EDT - 1 year ago

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

Jul 29, 2024, 4:05 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

Jul 26, 2024, 9:00 AM EDT - 1 year ago

Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

Jul 25, 2024, 8:30 AM EDT - 1 year ago

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

Jul 11, 2024, 9:00 AM EDT - 1 year ago

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

HeartSciences Regains Compliance with Nasdaq Listing Requirements

Jun 4, 2024, 4:15 PM EDT - 1 year ago

HeartSciences Regains Compliance with Nasdaq Listing Requirements

HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio

May 20, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

Apr 24, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

HeartSciences to Present at the LD Micro Invitational XIV Conference

Apr 2, 2024, 4:15 PM EDT - 2 years ago

HeartSciences to Present at the LD Micro Invitational XIV Conference

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

Mar 26, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

Mar 14, 2024, 4:15 PM EDT - 2 years ago

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

Mar 12, 2024, 9:00 AM EDT - 2 years ago

HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

Mar 6, 2024, 9:00 AM EST - 2 years ago

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

HeartSciences Adds Key Advisor to its Scientific Advisory Board

Feb 26, 2024, 9:00 AM EST - 2 years ago

HeartSciences Adds Key Advisor to its Scientific Advisory Board

HeartSciences Expands its Scientific Advisory Board

Feb 12, 2024, 9:00 AM EST - 2 years ago

HeartSciences Expands its Scientific Advisory Board

HeartSciences Appoints New Scientific Advisory Board Member

Feb 1, 2024, 9:00 AM EST - 2 years ago

HeartSciences Appoints New Scientific Advisory Board Member

HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting

Jan 18, 2024, 8:00 AM EST - 2 years ago

HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting

HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting

Jan 3, 2024, 4:15 PM EST - 2 years ago

HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting

HeartSciences Reports Second Quarter Fiscal 2024 Financial Results

Dec 14, 2023, 4:15 PM EST - 2 years ago

HeartSciences Reports Second Quarter Fiscal 2024 Financial Results

HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway

Dec 5, 2023, 8:00 AM EST - 2 years ago

HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway

HeartSciences' MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police Officers

Nov 13, 2023, 8:45 AM EST - 2 years ago

HeartSciences' MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police Officers

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

Nov 3, 2023, 8:28 AM EDT - 2 years ago

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

ARQT SINT

HeartSciences Reports First Quarter Fiscal 2024 Financial Results

Sep 14, 2023, 4:15 PM EDT - 2 years ago

HeartSciences Reports First Quarter Fiscal 2024 Financial Results

HeartSciences to Present at the Gilmartin Group Emerging Growth Showcase

Sep 12, 2023, 4:15 PM EDT - 2 years ago

HeartSciences to Present at the Gilmartin Group Emerging Growth Showcase

HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence Awards

Sep 11, 2023, 4:15 PM EDT - 2 years ago

HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence Awards

HeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, India

Sep 7, 2023, 9:00 AM EDT - 2 years ago

HeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, India

14745Barclay
14745Barclay Apr. 5 at 3:48 AM
$HSCS The COO died of cancer. Is the company finally able to do something substantial now? He was largely missing from operation due to illness.
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 3 at 1:17 AM
$HSCS
0 · Reply
StarlinePalaceTrades
StarlinePalaceTrades Apr. 2 at 5:55 PM
$HSCS that s-1 open or no?
0 · Reply
Moneyybaggs
Moneyybaggs Apr. 1 at 8:48 AM
$HSCS @DrTampa, somebody else, besides you and me, was FINALLY buying the stock yesterday!!! Let’s hope they’re back buying today. There is hardly any liquidity. SP was up 11% on just under 19K being traded. There’s hardly any shares in the float. Good luck building a sizable position without moving the SP $1-2. That PR last week regarding EPIC selection as a vendor in their web store is a GAME CHANGER!!! We are on the right train!!! UNCONTROLLABLY
1 · Reply
DrTampa
DrTampa Mar. 31 at 7:23 PM
$HSCS Nice inflow today with the share price up 11%
0 · Reply
DrTampa
DrTampa Mar. 30 at 4:43 PM
$HSCS that mid day spread tho 👀👀👀
0 · Reply
DrTampa
DrTampa Mar. 30 at 1:23 AM
$HSCS was so busy I missed this PR release last week, but it's now official news that Heart Sciences is listed on EPIC'S showroom! Now, we just need revenues!!! https://ir.heartsciences.com/release?i=163521
0 · Reply
PrnceMichael
PrnceMichael Mar. 27 at 2:42 PM
$OLOX $GMEX $GVH $UCAR $HSCS
0 · Reply
lovelylee
lovelylee Mar. 27 at 1:17 PM
$AIFU $GVH $HSCS $OSRH $UCAR $OSRH- best opportunity today! $10 price target, no dilution, low entry
0 · Reply
Verdelechugita
Verdelechugita Mar. 27 at 12:20 PM
$OLOX Based on news, fundamentals, and the exaggerated drop, it should already be above $1.60. Personal opinion. ✔️Likely big bounce ✔️Small market cap ✔️No short positions ✔️Small free float March 9th: $1.20 to $2.19 🚀 Today it's at $1.05... volume is coming in, interest is returning 👀 Today's pre-market Gainers 🚀 $GMEX $GVH $UCAR $HSCS
0 · Reply
topstockalerts
topstockalerts Mar. 27 at 11:40 AM
Pre Market Top Gainers PT2 $GVH $UCAR $HSCS $AIFU $OSRH
0 · Reply
topstockalerts
topstockalerts Mar. 27 at 11:07 AM
Pre Market Top Gainers PT2 $GMEX $XRTX $SGML $HSCS $MNTK
0 · Reply
Moneyybaggs
Moneyybaggs Mar. 27 at 10:37 AM
$HSCS I’m nipping at your heals with 142,000 shares!!! LFGOOOOOOOOOO HSCS!!!
1 · Reply
DrTampa
DrTampa Mar. 27 at 3:55 AM
$HSCS got me almost to 5% of the float with with 155,000+ shares stacked up! How you keeping up @Moneyybaggs?!?
0 · Reply
Moneyybaggs
Moneyybaggs Mar. 26 at 12:43 AM
$HSCS That’s a BINGO @14745Barclay!!! Nice DD. It’s only a matter of time before HSCS unleashes HOLY HELL!!! Exciting times. EPIC has validated HSCS’s intellectual property!!! PHENOMENALLY
2 · Reply
14745Barclay
14745Barclay Mar. 25 at 9:26 PM
$HSCS At the hospital where I am working full time, we use EPIC for everything. I was just clicking around this morning and Insight is definitely in the EPIC Showroom. Our hospital is a level one Trauma Center with multiple other hospitals in our Health System.
1 · Reply
Moneyybaggs
Moneyybaggs Mar. 25 at 1:12 AM
$HSCS VALIDATION FOR MYOVISTA INSIGHTS!!!
0 · Reply
DrTampa
DrTampa Mar. 24 at 11:52 PM
$HSCS this is very Epic that Heart Sciences is on the Epic showroom! This only adds validation that their product works, Epic wouldn't be adding it to their showroom if they hadn't vetted the software. Alongside earnings, Simpson commented that there are big contracts announcements that should be coming soon so I'm excited to hear if there is revenue guidance as well! LFG make that DOHHH Simpson!
1 · Reply
Moneyybaggs
Moneyybaggs Mar. 24 at 7:05 PM
$HSCS This relationship with EPIC could/will be a GAME CHANGER!!! DAMN!!!
0 · Reply
Moneyybaggs
Moneyybaggs Mar. 24 at 7:01 PM
$HSCS https://showroom.epic.com/Search?q=ECG+management+system Did a deep research dive into HSCS via Perplexity and ChatGPT and look what I discovered. Strap in HSCS investors, it’s about to get crazy!!! FREAKISHLY
1 · Reply
DrTampa
DrTampa Mar. 23 at 6:05 PM
$HSCS 153,000+ shares strong and still accumulating 🫡🤘
1 · Reply
TheUnmaker
TheUnmaker Mar. 19 at 4:07 PM
$TNXP I'm waiting for my $GRAL type run on this. Ran $GRAL from under $30 to $115+. I'm considering $HSCS soon also to run through when the time is right. Potential $30 squeeze play.
0 · Reply